⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.
METTL13–Foxa1–HES-1 Axis in BMSC Senescence
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-07-15 — Osteoimmune senescence in aging-related bone diseases.: cross-connection with inflammaging: Places METTL13-driven BMSC senescence within the osteoimmune-senescence concept, linking a stromal senescence regulator to the bone-compartment SASP feeding systemic inflammaging. (novelty: 3)
- 2026-08-10 — Youthfulness of marrow Adipoqcells maintained by Cbfβ facilitates stem cell-based bone repair.: cross-connection with cbfb-marrow-adipoq-bone-repair-axis: Both nominate distinct chromatin/epigenetic regulators (Cbfβ-controlled chromatin accessibility in Adipoq+ marrow cells vs METTL13–Foxa1–HES-1 in BMSCs) as upstream gatekeepers of marrow stromal senescence and osteogenic/adipogenic niche integrity in aged bone. (novelty: 3)
- 2026-07-09 — Cell-Type-Specific Calibration of Mitochondrial Ubiquitination in Stem Cell Fate Decisions.: cross-connection with pink1-parkin-mitophagy: Both position MSC/BMSC senescence as governed by upstream post-translational programs — mitochondrial ubiquitination (WAC–PINK1–Parkin) versus lysine methylation (METTL13/Foxa1/HES-1) — nominating parallel druggable nodes on stromal stem-cell aging. (novelty: 3)
- 2026-07-01 — Lysine methyltransferase methyltransferase-like 13 regulates bone marrow mesenchymal stem cells osteo-adipogenic differentiation and senescence in osteoporosis via the Foxa1/HES-1 axis.: 2026 preclinical study (ovariectomy osteoporosis model + BMSC culture): METTL13 knockdown reversed etoposide-induced BMSC senescence and restored osteogenic over adipogenic differentiation via a Foxa1/HES-1 transcriptional axis, nominating METTL13 as an upstream regulator of BMSC lineage-and-senescence balance in postmenopausal bone loss. [animal-model] (novelty: 3)